Company Overview of Ventria Bioscience, Inc.
Ventria Bioscience, Inc., a biotechnology company, develops, manufactures, and markets health and nutrition products. The company focuses on developing products in human nutrition and human therapeutics. Its product portfolio includes lactoferrin and lysozyme glycoproteins, which are used for gastrointestinal health, dietary management of acute diarrhea, treatment of topical infections and inflammations, and alleviation of fungal infections. The company also provides BioShare program for researchers, which provides access to a supply of recombinant proteins and peptides for research ideas. Ventria Bioscience, Inc. was founded in 1993 and is based in Fort Collins, Colorado.
PO Box 273330
Fort Collins, CO 80527
Founded in 1993
Key Executives for Ventria Bioscience, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ventria Bioscience, Inc., please visit www.ventriabio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.